Latest News about MRK
Recent news which mentions MRK
3 Dow Stocks That Are Screaming Buys in November
November 09, 2021
From Motley Fool
Should You Buy Pfizer Stock After the Fantastic COVID-19 Pill News?
November 09, 2021
From Motley Fool
Merck Ahead Of Pfizer In Talks With Europe For COVID-19 Pills: Reuters
November 08, 2021
From Benzinga
Caterpillar, Fluor, and ChargePoint Among Companies That Could Benefit from Infrastructure Bill
November 08, 2021
From Benzinga
Why BioNTech Stock Is Bouncing Back Today
November 08, 2021
From Motley Fool
Are Vaccine Stocks A Buy On Earnings?
November 08, 2021
From InvestorPlace
Why Moderna Stock Faltered In October
November 08, 2021
From Motley Fool
Here's Why Merck Stock Vaulted Higher in October
November 08, 2021
From Motley Fool
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
3 Best Biotech Stocks to Buy in November
November 08, 2021
From Motley Fool
Is Bristol Myers Squibb's Reported Acquisition of Aurinia a Smart Move?
November 06, 2021
From Motley Fool
Will Pfizer Outgun Merck With Oral COVID-19 Pill?
November 05, 2021
From Benzinga
A Deep Dive Into COVID Oral Treatments — What Does the Atea Failure Mean for Oral Antivirals?
November 05, 2021
From Benzinga
Why Vir Biotechnology Stock Is Sliding Today
November 05, 2021
From Motley Fool
Dow Jones Gains 300 Points on Jobs Report, Merck Shares Slammed on Pfizer's COVID Pill Results
November 05, 2021
From Motley Fool
Why BioNTech Stock Is Plunging Today
November 05, 2021
From Motley Fool
Pfizer COVID-19 Pill Adds Momentum to the Reopening Trade
November 05, 2021
From Benzinga
Pfizer to seek authorization of COVID-19 pill ‘as soon as possible’
November 05, 2021
From MarketWatch
Pfizer’s positive antiviral news raises hopes for a new easy-to-take treatment for COVID-19, and cases start to rise again in California
November 05, 2021
From MarketWatch
Todos Medical Says It Wants to Outfox COVID-19 & Cancer Along With Rivals Pfizer & Merck With New Theranostic Approach
November 05, 2021
From Benzinga
Why Pfizer Gained $32 Billion in Market Capitalization Today
November 05, 2021
From Motley Fool
A Deep Dive Into COVID Oral Treatments — What Does the Atea Failure Mean for Oral Antivirals?
November 05, 2021
From Benzinga
2 Buffett Stocks That Look Like Great Buys in November
November 05, 2021
From Motley Fool
Pfizer Touts Encouraging Data For Its COVID-19 Oral Antiviral, With 89% Reduction In Hospitalization, Death
November 05, 2021
From Benzinga
Is It Too Late to Buy Pfizer Stock?
November 05, 2021
From Motley Fool
3 COVID Pill Stocks That Might Be Game-Changers
November 05, 2021
From Motley Fool
The Novavax Rebound Is Just Warming Up
November 05, 2021
From InvestorPlace
Merck Receives Another Boost for Its Top-Selling Drug
November 04, 2021
From Motley Fool
Why AbCellera Biologics Stock Sank 21.6% in October
November 04, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.